A recent lawsuit in Florida targeting a medical organization that endorses child sex reassignment procedures has hit a snag, as a federal judge from nearly 1,000 miles away deemed the case “weak.” This has sparked a legal debate regarding whether federal judges from more liberal states can limit the enforcement of conservative policies in red states. This week, a federal judge appointed by Clinton in Illinois ruled against Florida Attorney General James Usmeyer, halting his prosecution of the American Academy of Pediatrics (AAP) for allegedly misleading parents and children regarding gender reassignment treatments for minors.
Usmeyer and other state attorneys general suggest this ruling raises concerns about federal overreach in judicial matters.
In December, Usmeyer initiated legal action against the AAP, the World Professional Association for Transgender Health (WPATH), and the Endocrine Society under the False Claims Act. He accused the AAP of deceptive practices by promoting gender reassignment procedures for minors as safe and reversible, without adequate scientific backing.
WPATH is a group comprised of medical professionals that sets standards for transgender surgeries. The AAP played a key role in urging WPATH to eliminate the minimum age requirement for irreversible sex reassignment in its revised guidelines from 2022, as previously noted.
Neither the AAP, WPATH, nor Usmeyer’s office responded to requests for comments. In March, the AAP countered by filing a lawsuit in federal court in Chicago against Usmeyer, with left-leaning courts so far siding against Florida. WPATH and the Endocrine Society are not part of this specific federal case.
On June 2, District Judge Matthew Kennelly ruled that Usmeyer’s Florida lawsuit could not move forward, issuing a restraining order that prevented Usmeyer from continuing his legal action against the AAP.
Judge Kennelly indicated that while the state attorney general has law enforcement priorities, the lack of substance in the Alabama complaint pointed towards a retaliatory action against the AAP without a realistic chance of winning.
The judge further explained that Usmeyer’s claims misrepresented the positions of both the AAP and WPATH concerning gender reassignment processes. He labeled the lawsuit as “conducted with malice and without a reasonable expectation of success.”
On Wednesday, Usmeyer appealed to the 7th Circuit Court of Appeals. The court denied his request to immediately lift the restraining order. Indiana, along with 21 other states, submitted amicus briefs supporting Usmeyer’s appeal.
In his appeal, Usmeyer argued that allowing federal courts to override state cases merely because they might reach a different conclusion would lead to an overextension of federal power.
He stated that no Florida court has ruled conclusively against his claims, suggesting that it’s plausible he could succeed in state court. However, the federal court instead seemed to judge the case based on its own perspective of what constitutes a “weak” claim.
Usmeyer’s office characterized Judge Kennelly’s decision as a historic but troubling move by the federal judiciary.
The injunction created by this ruling raises concerns about states’ rights, emphasizing that a federal judge from afar should not dictate the ability of Florida to pursue enforcement based on state law. Usmeyer’s filing argued that halting the state lawsuit means that Florida would suffer from being told by a distant federal judge that state enforcement actions cannot proceed.
On June 2, Judge Kennelly reinforced Usmeyer’s argument that jurisdiction was inappropriate, as “a federal court may preempt a state action brought in malice or harassment.”
The AAP contended that Usmeyer’s emergency appeal would compel him to restart an unconstitutional enforcement action in Florida that had already been deemed harmful to the AAP.
The AAP defended its position based on free speech, stating that its claims regarding false advertising were irrelevant, given that it doesn’t directly profit from sex reassignment procedures.
Kennelly acknowledged that while AAP’s guidelines seemed to endorse gender-affirming care, they maintained a focus on scientific and medical advocacy rather than appearing to be a profit-driven effort.
The AAP has drawn scrutiny for its guidelines on gender transition processes for minors. A recent review in the UK raised concerns that these guidelines may not meet established clinical practice standards.
